Immune responses against a virus-related skin cancer suggest ways to improve immunotherapy Fred Hutchinson … – EurekAlert (press release)
EurekAlert (press release) |
Immune responses against a virus-related skin cancer suggest ways to improve immunotherapy Fred Hutchinson …
EurekAlert (press release) In April, Nghiem's group published findings of a phase 2 clinical trial of the immunotherapy drug pembrolizumab, reporting that the "checkpoint inhibitor" helped to revive "exhausted" T cells, providing significant and lasting responses in more than … |
